csirt@kutim:~/threat-intel/cve/CVE-2026-7761

Katalog CVE

CVSS 8.8 · High EPSS 0,72%

Kerentanan Missing Authorization. Skor CVSS 3.1 8.8 (High) menurut wordfence.com.

Deskripsi (NVD)

The Ultimate Member plugin for WordPress is vulnerable to Account Takeover via Password Reset Link Disclosure in all versions up to and including 2.11.4. This is due to a chain of three logic bugs: (1) an MD5 hash fallback in get_directory_by_hash() that allows any post to be used as a member directory by computing SUBSTRING(MD5(post_id), 11, 5), (2) a strstr() parsing logic flaw in post_data() that allows bypassing WordPress's protected meta key restrictions by placing '_um_' anywhere in the meta key name rather than at the start, and (3) missing field name validation in build_user_card_data() that allows arbitrary field names including 'password_reset_link' to be passed to um_filtered_value(). This makes it possible for authenticated attackers with Contributor-level access and above to create a malicious post via XMLRPC with crafted meta fields, use the MD5 fallback to point the member directory AJAX handler to their post, inject 'password_reset_link' into the tagline_fields configuration, and leak live password reset URLs for all users in the member directory response, including administrators.

Rincian

Terbit di NVD
24 Juni 2026
Terakhir diubah
25 Juni 2026
Status NVD
Deferred
CVSS 3.1
8.8 (High), sumber wordfence.com
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-862: Missing Authorization
EPSS (30 hari)
0,72% peluang dieksploitasi; lebih tinggi dari 52,8% CVE lain

Produk dan versi terdampak

NVD belum mencantumkan data produk (CPE) untuk CVE ini. Produk yang terdampak biasanya disebut di deskripsi dan di advisory vendor pada daftar referensi.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.